Filter frequently asked questions by topic or search the database for specific keywords.
The PrediSpot test can be used to assess whether a patient is at an increased risk of developing:
DNA is isolated from blood or swab sample and used as template in quantitative polymerase chain reaction (qPCR) reactions to identify genetic markers, called single nucleotide polymorphisms (SNPs) associated with an increased risk of developing serious medical conditions. On the final report, you get information about the outcome of each polymorphisms studied.
Genetic polymorphisms are associated with susceptibility to different diseases. PrediSpot based on study of specific polymorphisms associated with different diseases.
DNA isolated from blood or swab sample and used as template in qPCR reactions using specific TaqMan Probes, for each polymorphism.
All reactions are performed in triplicate. In addition, positive and appropriate negative controls ensure accurate and reliable results.
The final PrediSpot test report provides information on whether scientists have identified any SNPs associated with serious health conditions and details of the testing process, which you can share with your patient.
Using the information from the PrediSpot, individuals are able get information about susceptibility to certain disease and therefore to make better-informed decisions about their health and wellbeing.
The PrediSpot test costs £750.
Results of the PrediSpot test are processed and returned within 14 days.
PaLDiSPOT is used for detection and determination of different Borrelia, Babesia and Bartonella genospecies using sensitive molecular biology techniques (quantitative Polymerase Chain Rreaction – qPCR).
